Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]
We ensure that candidates do not have contraindications, such as a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, to minimize potential risks associated with the medication
The timepoint chosen (when drug-tolerant cells are emerging after treatment) probably contributes to this effect, and later timepoints (when cells perhaps enter senescence or other more terminally arrested states) are more likely to reflect the expected gene expression patterns
Hypoglycemia with GLP-1 monotherapy is rare
ISBN 3527306730
Pathogens and the host immune response collectively dysregulate intracellular iron metabolism and ROS levels, ultimately leading to membrane damage via lipid peroxidation (Amaral and Namasivayam, 2021)